title: Bevacizumab for retinopathy of prematurity.
authors.forename: Laurence S
authors.initials: LS
authors.lastname: Lim
authors.forename: Paul
authors.initials: P
authors.lastname: Mitchell
authors.forename: Tien Y
authors.initials: TY
authors.lastname: Wong
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001835:Body Weight; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections; D053685:Laser Therapy; D012107:Research Design; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab